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Two Novel Single–Base-Pair Substitutions Adjacent to
the CAG Repeat in the Huntington Disease Gene
(IT15): Implications for Diagnostic Testing
To the Editor:
The CAG-expansion mutation that causes Huntington
disease (HD) was first identified in 1993 (Huntington’s
Disease Collaborative Research Group 1993). The stan-
dard PCR assay used by clinical laboratories to deter-
mine repeat length amplifies only the CAG repeat
(Andrew et al. 1994; The ACMG/ASHG Huntington
Disease Genetic Testing Working Group 1998). The ad-
jacent CCG repeat varies in length by 7–12 triplets (An-
drew et al. 1994), and the CCT repeat following the
CCG repeat can be either two (common) or three (rare)
triplets in length (Pecheux et al. 1995). A PCR assay
that amplifies across all three repeats (referred to as the
“CAGCCG assay”), taking advantage of the common
CCG repeat–length polymorphism, remains valuable for
the detection of a second allele in cases in which only a
single allele is detected by the CAG-only method (Gold-
berg et al. 1993; The ACMG/ASHGHuntington Disease
Genetic Testing Working Group 1998). By use of a third
assay, which determines the combined length of the CCG
and CCT repeats (referred to as the “CCG-only assay”;
Andrew et al. 1994), CAG-repeat length can be calcu-
lated. Previously, an apparently rare mutation was iden-
tified, in which the CAA triplet immediately following
the CAG repeat is absent, leading to failure of the stan-
dard PCR assay for repeat length (Gellera et al. 1996).
We now report two additional single-base substitutions
that can lead to assay failure or errors in the calculation
of CAG-repeat length.
In the first case, a 51-year-old man with a 14-year
history of a progressive syndrome typical of HD was
referred for testing for the HD expansion mutation. His
father had died, at age 56 years, of a myocardial in-
farction, and an extensive review of the pedigree revealed
no affected relatives. After informed consent was ob-
tained, DNA was extracted from blood (Gentra). The
CAG-only assay (fig. 1A) yielded a single peak, indicat-
ing a CAG-repeat length of 19 triplets. The CCG-only
assay (fig. 1A) generated two peaks, indicating the pres-
ence of alleles containing 7 and 10 CCG triplets. The
CAGCCG assay yielded a single peak consistent with
a CAG-repeat length of 19 or 20 triplets. A new 5′ primer
was synthesized that was identical to HD1, except for
the absence of the 3′ terminal C. By use of this primer
and primer HD2, the normal length CAG repeat of 20
triplets and an expanded repeat of 41 triplets were
detected.
To establish the reason for the failure of the original
HD1 primer to amplify the expanded repeat, genomic
DNA was reamplified by use of primers HD7-5′ (5′-
GGACGGCCGCTAGGTTC-3′) and HD7-3′ (5′-CGG-
CTGAGGAAGCTGAGGAGG-3′) and a PCR protocol
similar to the original CAG-only assay. PCR products
were cloned into pCRII (Invitrogen), and sequence was
obtained from three independent clones containing the
expanded allele. Each clone had an expanded CAG re-
peat of 41 triplets, as predicted by the assay with the
shortened HD1 primer, that was adjacent to a CCG re-
peat of 7 triplets. The sequence also revealed the presence
of a CrG substitution of the base immediately preceding
the CAG repeat (fig. 1B).
In the second case, an unaffected spouse of a patient
with HD was tested for HD repeat lengths, after in-
formed consent was obtained, as part of a presympto-
matic testing protocol for her child. The CAG repeats
determined by the CAG-only assay were 17 and 28 trip-
lets in length. The CCG-only assay yielded a single peak,
suggesting two CCG alleles of seven triplets each. The
CAGCCG assay indicated the presence of an allele of
(CAG)17, as expected, and a second allele of (CAG)30,
two triplets longer than was predicted by the other as-
says. To account for this discrepancy, genomic DNAwas
amplified, and the products were cloned into pCRII, as
described above. Interpretable sequences were obtained
from 11 clones. Eight clones contained a normal allele
with, as expected, 7 CCG triplets and either 16 (three
clones) or 17 (five clones) CAG triplets. Three clones
contained a second allele with either 26 (one clone) or
27 (two clones) CAG triplets. In all three of these clones,
the CCG repeat consisted of 12 consecutive CCG triplets
without the CCA triplet that normally precedes the CCG
repeat (fig. 1B).
The sequence of the regions adjacent to the CAG re-
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Figure 1 A, Repeat region of the HD gene (GenBank accession
number L12392, base pairs 316–585) and primers used for amplifi-
cation of the CAG repeat (HD1 and HD3-3′), the CCG repeat (HD3-
5′ and HD2), and the combined CAG/CCG repeat (HD1 and HD2).
For the CAG-only protocol, 500 ng genomic DNA was incubated at
99C for 3 min; 400 nM each of primer HD1 and fluorescently tagged
primer HD3-3′, 2.5 U Taq polymerase, and buffer containing 50 mM
Tris-HCl (pH 8.3), 50 mM KCL, 200 mM each dNTP, 1.5 mMMgCl2,
and 8# MasterAmp PCR enhancer (Epicenter Technologies) were
added, followed by denaturation at 95C for 5 min; 33 cycles of 95C
for 45 s, 67C for 45 s, and 72C for 1 min; and an extension at 72C
for 7 min. The CCG-only protocol was as described above, except
that annealing was at 60C and the buffer contained 50 mM KCl, 10
mM Tris-HCl (pH 8.3), 1 mM MgCl2, .01% gelatin, 10% dimethyl
sulfoxide, 1.5 U Taq polymerase, 100 mMdGTP, 100 mMdeaza-dGTP,
and 200 mM each of dATP, dTTP, and dCTP. The CAGCCGprotocol
was as described elsewhere (Huntington’s Disease Collaborative Re-
search Group 1993; Stine et al. 1993), modified for automated fluo-
rescent analysis. All assays are1 triplet. B, Three substitutions iden-
tified in the repeat region of the HD gene.
peat provides an explanation for the PCR results in these
two cases. In the first case, the CrG substitution falls
precisely at the 3′ terminal base of the HD1 PCR primer,
apparently preventing efficient annealing of this primer
and, hence, synthesis of a product. The substitution re-
sults in a change from phenylalanine to leucine in the
encoded protein. The clinical phenotype of the first case
is typical of HD, and this substitution of one neutral
hydrophobic amino acid for another possibly has no
consequences on phenotype. Among the 1,236 subjects
that we have tested for HD repeat length, this is the only
case for which the HD1 primer has failed consistently,
suggesting that this CrG substitution is a rare mutation.
The ArG polymorphism in the second case is silent,
because both codons encode proline. The absence of the
CCA codon in the second case presumably led to the
misannealing of primer HD3-5′, which caused the false
finding of a CCG repeat of seven triplets. In 26 other
subjects tested with all three assays (CAG-only, CCG-
only, and CAGCCG), we did not detect a repeat-length
discrepancy of two triplets, suggesting that absence of
the CCA repeat is a relatively uncommon variant. The
actual (CCG)12 repeat probably indicates the common
(CCG)10 variant coupled with an ArG substitution that
converts the adjacent CCACCG sequence into CCG-
CCG. However, other combinations of deletions and in-
sertions also could have resulted in this change. The
variation in length among the cloned PCR products of
the HD region of the second case may reflect either re-
peat-length instability during plasmid replication in bac-
teria or somatic variation of the repeat in leukocytes
from the subject.
These two variants have implications for the deter-
mination of the repeat length in the HD gene. The first
case demonstrates that test results indicative of CAG
repeat–length homozygosity may be incorrect, particu-
larly if the standard primer, HD1, is used. For cases in
which both the CAG-only and the CAGCCG assays
detect a single repeat, a reasonable next step would be
to repeat the assays, with the HD1-short primer. If this
assay or other PCR assays using alternative primers fail
to reveal a second allele, then a search, by Southern blot
analysis, for an expanded allele would be prudent. Sim-
ilarly, the second case suggests the use of an alternative
primer in those cases for which CCG-repeat length is
important but for which the standard assays of repeat
length yield discrepant results. More broadly, these cases
illustrate the pitfalls inherent in PCR-based assays of
genetic mutations.
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